Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing

Mee Young Ahn, Dong O. Kang, Yong Jin Na, Sungpil Yoon, Whan Soo Choi, Keun Wook Kang, Hae Young Chung, Jee H. Jung, Do Sik Min, Hyung Sik Kim

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

This study examined the molecular mechanisms of apicidin in the modulation of human ovarian cancer SKOV-3 cells invasion and migration. Apicidin markedly decreased histone deacetylase 4 (HDAC4) expression and blocked cell migration and invasion. Cell migration was inhibited via down-regulation of matrix metalloproteinase-2 (MMP-2) and up-regulation of RECK in the HDAC4-blocked SKOV-3 cells. Apicidin significantly suppressed the binding of HDAC4 to Sp1 binding elements of the RECK promoter via repression of HDAC4. In an in vivo model, apicidin suppressed the growth of transplanted SKOV-3 cells by down-regulating HDAC4 and MMP-2. Apicidin may potentially be used as an anti-cancer agent for inhibition of cancer cell migration and invasion through the repression of MMP-2 which is related to the reduction of HDAC4.

Original languageEnglish
Pages (from-to)189-199
Number of pages11
JournalCancer Letters
Volume325
Issue number2
DOIs
Publication statusPublished - 2012 Dec 28

Fingerprint

Histone Deacetylase Inhibitors
Histone Deacetylases
Ovarian Neoplasms
Cell Movement
Matrix Metalloproteinase 2
Cell Migration Inhibition
apicidin
Neoplasms
Up-Regulation
Down-Regulation
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Ahn, Mee Young ; Kang, Dong O. ; Na, Yong Jin ; Yoon, Sungpil ; Choi, Whan Soo ; Kang, Keun Wook ; Chung, Hae Young ; Jung, Jee H. ; Min, Do Sik ; Kim, Hyung Sik. / Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing. In: Cancer Letters. 2012 ; Vol. 325, No. 2. pp. 189-199.
@article{1c30c8676f0d4029ade24a110a1af3e5,
title = "Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing",
abstract = "This study examined the molecular mechanisms of apicidin in the modulation of human ovarian cancer SKOV-3 cells invasion and migration. Apicidin markedly decreased histone deacetylase 4 (HDAC4) expression and blocked cell migration and invasion. Cell migration was inhibited via down-regulation of matrix metalloproteinase-2 (MMP-2) and up-regulation of RECK in the HDAC4-blocked SKOV-3 cells. Apicidin significantly suppressed the binding of HDAC4 to Sp1 binding elements of the RECK promoter via repression of HDAC4. In an in vivo model, apicidin suppressed the growth of transplanted SKOV-3 cells by down-regulating HDAC4 and MMP-2. Apicidin may potentially be used as an anti-cancer agent for inhibition of cancer cell migration and invasion through the repression of MMP-2 which is related to the reduction of HDAC4.",
author = "Ahn, {Mee Young} and Kang, {Dong O.} and Na, {Yong Jin} and Sungpil Yoon and Choi, {Whan Soo} and Kang, {Keun Wook} and Chung, {Hae Young} and Jung, {Jee H.} and Min, {Do Sik} and Kim, {Hyung Sik}",
year = "2012",
month = "12",
day = "28",
doi = "10.1016/j.canlet.2012.06.017",
language = "English",
volume = "325",
pages = "189--199",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing. / Ahn, Mee Young; Kang, Dong O.; Na, Yong Jin; Yoon, Sungpil; Choi, Whan Soo; Kang, Keun Wook; Chung, Hae Young; Jung, Jee H.; Min, Do Sik; Kim, Hyung Sik.

In: Cancer Letters, Vol. 325, No. 2, 28.12.2012, p. 189-199.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing

AU - Ahn, Mee Young

AU - Kang, Dong O.

AU - Na, Yong Jin

AU - Yoon, Sungpil

AU - Choi, Whan Soo

AU - Kang, Keun Wook

AU - Chung, Hae Young

AU - Jung, Jee H.

AU - Min, Do Sik

AU - Kim, Hyung Sik

PY - 2012/12/28

Y1 - 2012/12/28

N2 - This study examined the molecular mechanisms of apicidin in the modulation of human ovarian cancer SKOV-3 cells invasion and migration. Apicidin markedly decreased histone deacetylase 4 (HDAC4) expression and blocked cell migration and invasion. Cell migration was inhibited via down-regulation of matrix metalloproteinase-2 (MMP-2) and up-regulation of RECK in the HDAC4-blocked SKOV-3 cells. Apicidin significantly suppressed the binding of HDAC4 to Sp1 binding elements of the RECK promoter via repression of HDAC4. In an in vivo model, apicidin suppressed the growth of transplanted SKOV-3 cells by down-regulating HDAC4 and MMP-2. Apicidin may potentially be used as an anti-cancer agent for inhibition of cancer cell migration and invasion through the repression of MMP-2 which is related to the reduction of HDAC4.

AB - This study examined the molecular mechanisms of apicidin in the modulation of human ovarian cancer SKOV-3 cells invasion and migration. Apicidin markedly decreased histone deacetylase 4 (HDAC4) expression and blocked cell migration and invasion. Cell migration was inhibited via down-regulation of matrix metalloproteinase-2 (MMP-2) and up-regulation of RECK in the HDAC4-blocked SKOV-3 cells. Apicidin significantly suppressed the binding of HDAC4 to Sp1 binding elements of the RECK promoter via repression of HDAC4. In an in vivo model, apicidin suppressed the growth of transplanted SKOV-3 cells by down-regulating HDAC4 and MMP-2. Apicidin may potentially be used as an anti-cancer agent for inhibition of cancer cell migration and invasion through the repression of MMP-2 which is related to the reduction of HDAC4.

UR - http://www.scopus.com/inward/record.url?scp=84865660690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865660690&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2012.06.017

DO - 10.1016/j.canlet.2012.06.017

M3 - Article

C2 - 22781396

AN - SCOPUS:84865660690

VL - 325

SP - 189

EP - 199

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -